PROVIDER PROFILE · NPI 1730688409

Narifa Aziz

MEDICARE UTILIZATION · PART B · 2024

No data available for this provider in 2024.

PRESCRIBING · PART D · 2024

Total Rx claims

475

Beneficiaries

—

Total drug cost

$3.3M

Distinct drugs

Brand share

52.8%

Top prescribed drugs

Apixaban32 claims

QUALITY · MIPS · 2024

Final MIPS score

79.1

Quality

57.9

Cost

80.4

Improvement activities

40.0

Promoting interop.

77.0

Payment adjustment

0.17%

Group

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

No data available for this provider in 2024.

CROSS-REFERENCE

Related data on other Healthparse brands